Application 206493
- Type
- ANDA
- Sponsor
- ACTAVIS MID ATLANTIC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | GEL;TOPICAL | 3% | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0472-1783 | Diclofenac Sodium | Diclofenac Sodium | Actavis Pharma, Inc. | ANDA | Current |
| 0472-1783 | Diclofenac Sodium | Diclofenac Sodium | Actavis Pharma, Inc. | ANDA | Current |
| 0472-1783 | Diclofenac Sodium | Diclofenac Sodium | Actavis Pharma, Inc. | ANDA | Current |
| 68788-7518 | Diclofenac Sodium | Diclofenac Sodium | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-7518 | Diclofenac Sodium | Diclofenac Sodium | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 76420-261 | Diclofenac Sodium | Diclofenac Sodium | Asclemed USA, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 10574 | ORIG | 2015-12-07 |